Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (141-150 of 500) with videos related to

Pageof 50
Sort By:
Transplantation and Cellular Therapy|November 14, 2025
CRISPR Knockdown of CHIP Genes in Macrophages Drives Increased Production of Inflammatory Cytokines in CAR-T Cell TherapyChunyan Zhang, Scott R Goldsmith, Myo Htut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2021
Novel Redirected T-Cell Immunotherapies for Advanced Prostate CancerTanya B Dorff, Vivek Narayan, Stephen J Forman, et al.
Blood|July 27, 2010
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor StudyCan-Lan Sun, Liton Francisco, Toana Kawashima, et al.
Transplantation|September 28, 2002
Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplantsSimon F Lacey, Ghislaine Gallez-Hawkins, Matthew Crooks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosisDavid S Snyder, Joycelynne Palmer, Anthony S Stein, et al.
Transplantation and Cellular Therapy|July 18, 2021
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant RecipientsHaris Ali, Dat Ngo, Ahmed Aribi, et al.
The Journal of Clinical Investigation|August 21, 2020
Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic miceYuqing Liu, Xiaoqi Wang, Yongping Zhu, et al.
Bone Marrow Transplantation|September 26, 2019
Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantationMonzr M Al Malki, Ketevan Gendzekhadze, Tracey Stiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trialPatrick J Stiff, Joseph M Unger, Stephen J Forman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T CellsChristine E Brown, Renate Starr, Brenda Aguilar, et al.
Pageof 50

Showing results (141-150 of 500) with videos related to

Sort By:
Pageof 50
Transplantation and Cellular Therapy|November 14, 2025
CRISPR Knockdown of CHIP Genes in Macrophages Drives Increased Production of Inflammatory Cytokines in CAR-T Cell TherapyChunyan Zhang, Scott R Goldsmith, Myo Htut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2021
Novel Redirected T-Cell Immunotherapies for Advanced Prostate CancerTanya B Dorff, Vivek Narayan, Stephen J Forman, et al.
Blood|July 27, 2010
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor StudyCan-Lan Sun, Liton Francisco, Toana Kawashima, et al.
Transplantation|September 28, 2002
Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplantsSimon F Lacey, Ghislaine Gallez-Hawkins, Matthew Crooks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosisDavid S Snyder, Joycelynne Palmer, Anthony S Stein, et al.
Transplantation and Cellular Therapy|July 18, 2021
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant RecipientsHaris Ali, Dat Ngo, Ahmed Aribi, et al.
The Journal of Clinical Investigation|August 21, 2020
Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic miceYuqing Liu, Xiaoqi Wang, Yongping Zhu, et al.
Bone Marrow Transplantation|September 26, 2019
Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantationMonzr M Al Malki, Ketevan Gendzekhadze, Tracey Stiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trialPatrick J Stiff, Joseph M Unger, Stephen J Forman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T CellsChristine E Brown, Renate Starr, Brenda Aguilar, et al.
Pageof 50